These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 20458083)

  • 1. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.
    Gray SL; LaCroix AZ; Larson J; Robbins J; Cauley JA; Manson JE; Chen Z
    Arch Intern Med; 2010 May; 170(9):765-71. PubMed ID: 20458083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrate Medications, Fractures, and Change in Bone Mineral Density in Postmenopausal Women: Results from the Women's Health Initiative.
    Golchin N; Hohensee C; LaCroix A; Gray SL
    J Bone Miner Res; 2016 Sep; 31(9):1760-6. PubMed ID: 26990305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study.
    LaCroix AZ; Cauley JA; Pettinger M; Hsia J; Bauer DC; McGowan J; Chen Z; Lewis CE; McNeeley SG; Passaro MD; Jackson RD
    Ann Intern Med; 2003 Jul; 139(2):97-104. PubMed ID: 12859159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
    Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE
    JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos).
    Targownik LE; Leslie WD; Davison KS; Goltzman D; Jamal SA; Kreiger N; Josse RG; Kaiser SM; Kovacs CS; Prior JC; Zhou W;
    Am J Gastroenterol; 2012 Sep; 107(9):1361-9. PubMed ID: 22777336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.
    LaFleur J; Rillamas-Sun E; Colón-Emeric CS; Knippenberg KA; Ensrud KE; Gray SL; Cauley JA; LaCroix AZ
    Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S78-90. PubMed ID: 26768394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) plasma levels, bone mineral density and risk of hip fracture: a post hoc analysis of the Women's Health Initiative, USA.
    Haring B; Crandall CJ; Carbone L; Liu S; Li W; Johnson KC; Wactawski-Wende J; Shadyab AH; Gass ML; Kamensky V; Cauley JA; Wassertheil-Smoller S
    BMJ Open; 2019 Apr; 9(4):e027257. PubMed ID: 31023762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
    J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss.
    Targownik LE; Lix LM; Leung S; Leslie WD
    Gastroenterology; 2010 Mar; 138(3):896-904. PubMed ID: 19931262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker-calibrated protein intake and bone health in the Women's Health Initiative clinical trials and observational study.
    Beasley JM; LaCroix AZ; Larson JC; Huang Y; Neuhouser ML; Tinker LF; Jackson R; Snetselaar L; Johnson KC; Eaton CB; Prentice RL
    Am J Clin Nutr; 2014 Apr; 99(4):934-40. PubMed ID: 24552750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Mineral Density as a Predictor of Subsequent Wrist Fractures: Findings From the Women's Health Initiative Study.
    Crandall CJ; Hovey KM; Andrews CA; Cauley JA; Manson JE; Wactawski-Wende J; Wright NC; Li W; Beavers K; Curtis JR; LeBoff MS
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4315-24. PubMed ID: 26367200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid-suppressive medications and risk of bone loss and fracture in older adults.
    Yu EW; Blackwell T; Ensrud KE; Hillier TA; Lane NE; Orwoll E; Bauer DC
    Calcif Tissue Int; 2008 Oct; 83(4):251-9. PubMed ID: 18813868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laxative use and incident falls, fractures and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.
    Haring B; Pettinger M; Bea JW; Wactawski-Wende J; Carnahan RM; Ockene JK; Wyler von Ballmoos M; Wallace RB; Wassertheil-Smoller S
    BMC Geriatr; 2013 May; 13():38. PubMed ID: 23635086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.
    Moberg LM; Nilsson PM; Samsioe G; Borgfeldt C
    Maturitas; 2014 Aug; 78(4):310-5. PubMed ID: 24958166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Barrett-Connor E; Miller PD; Sajjan S; Berger ML; Chen YT
    Osteoporos Int; 2006; 17(4):565-74. PubMed ID: 16392027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between soft drink consumption and osteoporotic fractures among postmenopausal women: the Women's Health Initiative.
    Kremer PA; Laughlin GA; Shadyab AH; Crandall CJ; Masaki K; Orchard T; Snetselaar L; LaCroix AZ
    Menopause; 2019 Nov; 26(11):1234-1241. PubMed ID: 31613830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program.
    Hodsman AB; Leslie WD; Tsang JF; Gamble GD
    Arch Intern Med; 2008 Nov; 168(20):2261-7. PubMed ID: 19001204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI).
    Carbone LD; Johnson KC; Robbins J; Larson JC; Curb JD; Watson K; Gass M; Lacroix AZ
    J Bone Miner Res; 2010 Apr; 25(4):873-81. PubMed ID: 19839772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study.
    Khalili H; Huang ES; Jacobson BC; Camargo CA; Feskanich D; Chan AT
    BMJ; 2012 Jan; 344():e372. PubMed ID: 22294756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive symptoms, bone loss, and fractures in postmenopausal women.
    Spangler L; Scholes D; Brunner RL; Robbins J; Reed SD; Newton KM; Melville JL; Lacroix AZ
    J Gen Intern Med; 2008 May; 23(5):567-74. PubMed ID: 18286345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.